Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Oct 15, 2024; 16(10): 4194-4208
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4194
Published online Oct 15, 2024. doi: 10.4251/wjgo.v16.i10.4194
Figure 5 Steroid receptor RNA activator 1 overexpression promotes phospholysine phosphohistidine inorganic pyrophosphate phosphatase expression in esophageal squamous cell carcinoma cells by sponging miRNA-363-5p.
A: The delivery of miRNA-363-5p mimic caused a prominent miRNA-363-5p upregulation in EC9706 and TE1 cells; B-D: Steroid receptor RNA activator 1 (SRA1) upregulation triggered an obvious overexpressed effect on the endogenous phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) mRNA and protein levels in EC9706 and TE1 cells, whereas the delivery of miRNA-363-5p mimic counteracted such effect; E: LHPP expression was positively correlated with SRA1 expression in ESCC tissues; F: SRA1, miRNA-363-5p, and LHPP were preferentially concentrated in the anti-Ago2 precipitate. aP < 0.01 vs NC; bP < 0.01 vs pcDNA3.1-SRA1 + miRNA-363-5p mimic; cP < 0.01 vs IgG; NC: Negative control; SRA1: Steroid receptor RNA activator 1; LHPP: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase.
- Citation: He M, Qi Y, Zheng ZM, Sha M, Zhao X, Chen YR, Chen ZH, Qian RY, Yao J, Yang ZD. Long noncoding RNA steroid receptor RNA activator 1 inhibits proliferation and glycolysis of esophageal squamous cell carcinoma. World J Gastrointest Oncol 2024; 16(10): 4194-4208
- URL: https://www.wjgnet.com/1948-5204/full/v16/i10/4194.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i10.4194